LINE-1 and Alu Methylation Levels Among Middle Aged Women With Low Cardiovascular Risk Profile in Respect of Menopausal Hot Flashes

计划入组 30 人 · 首次发布于 2023 年 6 月 7 日

Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy

计划入组 35 人 · 首次发布于 2025 年 3 月 11 日

HEBE Project - Healthy Aging Versus Inflamm-aging: the Role of Physical Exercise in Modulating the Biomarkers of Age-associated and Environmentally Determined Chronic Diseases

计划入组 100 人 · 首次发布于 2023 年 4 月 18 日

LINE-1 Reverse Transcriptase Inhibitor (Rome Therapeutics)

1-naphthaleneacetic acid

C₁₂H₁₀O₂

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

China

ZHEJIANG　MEDICINE Co., Ltd.

3D MEDICINES

Hong Kong, China

ROME Therapeutics Presents Data on LINE-1 Reverse Transcriptase Inhibitors for Autoimmune Diseases

ROME Therapeutics Presents Data on LINE-1 Reverse Transcriptase Inhibitors for Autoimmune Diseases

ROME Therapeutics' Landmark Study Reveals Novel LINE-1 Activity Patterns Across Cancer Types